| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |